Daniela Furrer
Quebec, QC G1V0A6, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Association between genome-wide epigenetic and genetic alterations in breast cancer tissue and response to HER2-targeted therapies in HER2-positive breast cancer patients: new findings and a systematic review.
Journal: Cancer drug resistance (Alhambra, Calif.)
Published: May 19, 2022
Discontinuation of bisphosphonates in seniors: a systematic review on health outcomes.
Journal: Archives of osteoporosis
Published: July 11, 2021
Association of Breast Tumour Expression of Cannabinoid Receptors CBR1 and CBR2 with Prognostic Factors and Survival in Breast Cancer Patients.
Journal: Journal of personalized medicine
Published: July 05, 2021
Cannabis against chronic musculoskeletal pain: a scoping review on users and their perceptions.
Journal: Journal of cannabis research
Published: January 08, 2021
Health Impacts and Characteristics of Deprescribing Interventions in Older Adults: Protocol for a Systematic Review and Meta-analysis.
Journal: JMIR research protocols
Published: October 21, 2020
Trastuzumab effects depend on HER2 phosphorylation in HER2-negative breast cancer cell lines.
Journal: PloS one
Published: January 23, 2020
NADH-linked mitochondrial respiration in the developing mouse brain is sex-, age- and tissue-dependent.
Journal: Respiratory physiology & neurobiology
Published: March 22, 2019
Performance of preoperative plasma tumor markers HE4 and CA125 in predicting ovarian cancer mortality in women with epithelial ovarian cancer.
Journal: PloS one
Published: January 25, 2019
Association of Tobacco Use, Alcohol Consumption and HER2 Polymorphisms With Response to Trastuzumab in HER2-Positive Breast Cancer Patients.
Journal: Clinical breast cancer
Published: May 25, 2017
MCM2: An alternative to Ki-67 for measuring breast cancer cell proliferation.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: September 27, 2016
Tissue Microarray Is a Reliable Tool for the Evaluation of HER2 Amplification in Breast Cancer.
Journal: Anticancer research
Published: July 04, 2016
Last Updated: 09/26/2026